JP2025172140A5 - - Google Patents
Info
- Publication number
- JP2025172140A5 JP2025172140A5 JP2025145434A JP2025145434A JP2025172140A5 JP 2025172140 A5 JP2025172140 A5 JP 2025172140A5 JP 2025145434 A JP2025145434 A JP 2025145434A JP 2025145434 A JP2025145434 A JP 2025145434A JP 2025172140 A5 JP2025172140 A5 JP 2025172140A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- composition according
- peptide
- terminus
- modification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862748711P | 2018-10-22 | 2018-10-22 | |
| US62/748,711 | 2018-10-22 | ||
| PCT/US2019/056955 WO2020086400A1 (en) | 2018-10-22 | 2019-10-18 | Cleavable activators of cxcr3 and methods of use |
| JP2021521472A JP7426121B2 (ja) | 2018-10-22 | 2019-10-18 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
| JP2023198254A JP7798368B2 (ja) | 2018-10-22 | 2023-11-22 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023198254A Division JP7798368B2 (ja) | 2018-10-22 | 2023-11-22 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025172140A JP2025172140A (ja) | 2025-11-20 |
| JP2025172140A5 true JP2025172140A5 (enExample) | 2026-03-30 |
Family
ID=70330587
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521472A Active JP7426121B2 (ja) | 2018-10-22 | 2019-10-18 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
| JP2023198254A Active JP7798368B2 (ja) | 2018-10-22 | 2023-11-22 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
| JP2025145434A Pending JP2025172140A (ja) | 2018-10-22 | 2025-09-02 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521472A Active JP7426121B2 (ja) | 2018-10-22 | 2019-10-18 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
| JP2023198254A Active JP7798368B2 (ja) | 2018-10-22 | 2023-11-22 | Ｃｘｃｒ３の切断可能な活性化因子および使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12110316B2 (enExample) |
| EP (1) | EP3870212A4 (enExample) |
| JP (3) | JP7426121B2 (enExample) |
| KR (1) | KR20210081372A (enExample) |
| CN (2) | CN120022352A (enExample) |
| AU (2) | AU2019365654B2 (enExample) |
| BR (1) | BR112021007414A2 (enExample) |
| CA (1) | CA3116325A1 (enExample) |
| IL (2) | IL324815A (enExample) |
| MX (1) | MX2021004496A (enExample) |
| SG (1) | SG11202103497WA (enExample) |
| WO (1) | WO2020086400A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210081372A (ko) * | 2018-10-22 | 2021-07-01 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 절단 가능한 cxcr3의 활성제 및 이의 사용 방법 |
| GB202208950D0 (en) * | 2022-06-17 | 2022-08-10 | Ucl Business Ltd | Treatment of the corneal endothelium |
| WO2024118744A2 (en) * | 2022-11-30 | 2024-06-06 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Coacervate formulations of cxcr3-activating peptides for controlled release in ophthalmic and topical treatments |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994292A (en) * | 1995-05-31 | 1999-11-30 | The United States Of America As Represented By The Department Of Health And Human Services | Interferon-inducible protein 10 is a potent inhibitor of angiogenesis |
| MXPA00003885A (es) | 1997-10-22 | 2004-04-23 | Inst Genetics Llc | Quimiocinas con modificiaciones de la terminacion amino. |
| US20070116669A1 (en) * | 2002-09-13 | 2007-05-24 | Chemokine Therapeutics Corporation | Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases |
| GB2377444A (en) | 2001-04-09 | 2003-01-15 | Smithkline Beecham Plc | Chemokine-family polypeptide |
| IL164942A0 (en) * | 2004-10-31 | 2005-12-18 | Yeda Res & Dev | The use of a protease or a protease inhibitor for the manufacture of medicaments |
| US9180167B2 (en) | 2011-08-26 | 2015-11-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Activators of CXCR3 for the treatment of angiopathies of the eye |
| US8734775B2 (en) | 2011-08-26 | 2014-05-27 | University Of Pittsburgh | Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments |
| AU2014306074B2 (en) * | 2013-08-05 | 2018-08-30 | Greenlight Biosciences, Inc. | Engineered proteins with a protease cleavage site |
| US9895419B2 (en) * | 2014-01-21 | 2018-02-20 | University of Pittsburgh—of the Commonwealth System of Higher Education | Goblet cell replacement therapy |
| ES2738582T3 (es) * | 2014-02-14 | 2020-01-23 | Immune Design Corp | Inmunoterapia del cáncer a través de combinación de inmunoestimulación local y sistémica |
| AU2017290828A1 (en) * | 2016-06-30 | 2019-01-24 | Virogin Biotech Canada Ltd | Pseudotyped oncolytic viral delivery of therapeutic polypeptides |
| JP7626577B2 (ja) | 2016-11-28 | 2025-02-07 | 中外製薬株式会社 | リガンド結合活性が調整可能なリガンド結合分子 |
| SG11201909160WA (en) * | 2017-04-11 | 2019-10-30 | Inhibrx Inc | Multispecific polypeptide constructs having constrained cd3 binding and methods of using the same |
| KR20210081372A (ko) | 2018-10-22 | 2021-07-01 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 절단 가능한 cxcr3의 활성제 및 이의 사용 방법 |
-
2019
- 2019-10-18 KR KR1020217014758A patent/KR20210081372A/ko active Pending
- 2019-10-18 CN CN202510050400.1A patent/CN120022352A/zh active Pending
- 2019-10-18 IL IL324815A patent/IL324815A/en unknown
- 2019-10-18 IL IL282431A patent/IL282431B2/en unknown
- 2019-10-18 CA CA3116325A patent/CA3116325A1/en active Pending
- 2019-10-18 BR BR112021007414-7A patent/BR112021007414A2/pt unknown
- 2019-10-18 US US17/287,480 patent/US12110316B2/en active Active
- 2019-10-18 JP JP2021521472A patent/JP7426121B2/ja active Active
- 2019-10-18 EP EP19875282.6A patent/EP3870212A4/en active Pending
- 2019-10-18 CN CN201980069480.8A patent/CN113038965B/zh active Active
- 2019-10-18 MX MX2021004496A patent/MX2021004496A/es unknown
- 2019-10-18 WO PCT/US2019/056955 patent/WO2020086400A1/en not_active Ceased
- 2019-10-18 SG SG11202103497WA patent/SG11202103497WA/en unknown
- 2019-10-18 AU AU2019365654A patent/AU2019365654B2/en active Active
-
2023
- 2023-11-22 JP JP2023198254A patent/JP7798368B2/ja active Active
-
2024
- 2024-08-28 US US18/817,667 patent/US20250002549A1/en active Pending
-
2025
- 2025-02-08 AU AU2025200880A patent/AU2025200880A1/en active Pending
- 2025-09-02 JP JP2025145434A patent/JP2025172140A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025172140A5 (enExample) | ||
| US7348401B2 (en) | Peptides that inhibit complement activation | |
| CN1154655C (zh) | k受体的阿片样肽 | |
| US7083983B2 (en) | Inhibitors of the interaction between P53 and MDM2 | |
| CA1339623C (en) | Lhrh antagonists | |
| CN101265299A (zh) | 来自杀菌性通透性增强蛋白的功能区的生物活性肽及其应用 | |
| AU2009327338B2 (en) | TFPI inhibitors and methods of use | |
| AU2017200588A1 (en) | Treatments for gastrointestinal disorders | |
| JP2023517293A5 (enExample) | ||
| RU2007110981A (ru) | Урокортин iii и его использование | |
| CA2945838C (en) | Modified relaxin b chain peptides | |
| JP2016065018A (ja) | Ｃｘｃｒ７結合剤およびｃｘｃｒ７結合剤を含有する医薬組成物 | |
| JP2023116739A5 (enExample) | ||
| JP2022512770A5 (enExample) | ||
| JP2023552824A (ja) | アルツハイマー病および関連状態を処置するためのペプチド治療薬 | |
| CA2410224A1 (en) | Peptide conjugates modified n- and/or c-terminally by short charged peptide chains | |
| JP2010505395A (ja) | 先天免疫を調節することによる感染の処置および予防を含む、免疫関連疾患障害の処置および予防のための新規ペプチド | |
| CN100577686C (zh) | 寡聚肽及其治疗hiv感染的用途 | |
| CN116178506A (zh) | 一种订书肽及其用途 | |
| KR20250042844A (ko) | 결장 세정을 위한 조성물 및 위장 장애의 치료 | |
| US6906037B2 (en) | Therapeutic peptide-based constructs | |
| CN101808655B (zh) | 衍生自纤溶酶原激活物抑制剂-1的肽和其应用 | |
| SK150196A3 (en) | Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use | |
| Zikos et al. | Comparative evaluation of four trityl‐type amidomethyl polystyrene resins in Fmoc solid phase peptide synthesis | |
| MXPA04002055A (es) | Compuestos peptidicos que enlazan selectivamente a p-selectina. |